by Truveta Staff | Feb 22, 2024 | Technology
The National Academy of Medicine has estimated that less than half of all medical care in the US is supported by adequate evidence of effectiveness. The proliferation of treatment options in some disease states and the rising costs of many of those treatments have...
by Truveta Staff | Nov 21, 2023 | Technology
ISPOR Europe 2023 provided Truveta an opportunity to showcase research findings, interact with life sciences leaders from across the globe, and gain insight into how different audiences view current challenges and opportunities related to real-world data (RWD). Here...
by Terry Myerson, CEO | Nov 2, 2022 | News
In just over two years — with amazing teamwork across Truveta and our 25 health system members, and strategic partnerships with customers like Pfizer and Boston Scientific — it is so exciting to announce the availability of Truveta Studio. It is amazing...
by Truveta Staff | Oct 11, 2022 | Culture
Truveta is a place for researchers, and this team works with the vast volume of data in Truveta Studio. They ask and answer critical clinical research questions, surface insights, conduct research studies, and partner with health system members and life science...
by Truveta Staff | Oct 5, 2022 | News
Let’s catch up We just hosted a LinkedIn Live, “Monitoring Medical Device Outcomes & Health Disparities,” with three Truveta leaders — our CEO, Terry Myerson; Chief Medical Officer, Dr. Ryan Ahern, MD, MPH; and VP of Communications, Lish Mark. They...
